These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1740647)

  • 1. Mouse T cell clones against Mycobacterium avium: identification of clones that modify resistance against atypical mycobacteria infection.
    Denis M
    J Leukoc Biol; 1992 Jan; 51(1):7-12. PubMed ID: 1740647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
    Denis M
    Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
    Denis M
    Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
    Castro AP; Aguas AP; Silva MT
    Clin Exp Immunol; 1993 Jun; 92(3):466-72. PubMed ID: 8513578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 is involved in mouse resistance to Mycobacterium avium.
    Denis M; Ghadirian E
    Infect Immun; 1994 Feb; 62(2):457-61. PubMed ID: 8300206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD; Bottomly K
    J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?
    Appelberg R
    Immunol Res; 2006; 35(3):179-90. PubMed ID: 17172645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and expression of protective T cells during Mycobacterium avium infections in mice.
    Appelberg R; Pedrosa J
    Clin Exp Immunol; 1992 Mar; 87(3):379-85. PubMed ID: 1544223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma.
    Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A
    Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
    Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
    J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice.
    Silva TR; Petersen AL; Santos Tde A; Almeida TF; Freitas LA; Veras PS
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):642-8. PubMed ID: 20835610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones.
    Hussein S; Curtis J; Akuffo H; Turk JL
    Infect Immun; 1987 Mar; 55(3):564-7. PubMed ID: 2950059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD40 ligand in Mycobacterium avium infection.
    Hayashi T; Rao SP; Meylan PR; Kornbluth RS; Catanzaro A
    Infect Immun; 1999 Jul; 67(7):3558-65. PubMed ID: 10377139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.
    Flórido M; Gonçalves AS; Silva RA; Ehlers S; Cooper AM; Appelberg R
    Infect Immun; 1999 Jul; 67(7):3610-8. PubMed ID: 10377146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.
    Stokes RW; Collins FM
    Clin Exp Immunol; 1990 Jul; 81(1):109-15. PubMed ID: 2116245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of colony-stimulating factors by T cell clones. Role in adoptive protection against Listeria monocytogenes.
    Magee DM; Wing EJ
    J Immunol; 1989 Oct; 143(7):2336-41. PubMed ID: 2674280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
    Appelberg R; Sarmento AM
    Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections.
    Denis M; Ghadirian E
    J Immunol; 1993 Nov; 151(10):5425-30. PubMed ID: 8228235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell immune responses in Mycobacterium avium-infected mice.
    Hubbard RD; Flory CM; Collins FM
    Infect Immun; 1992 Jan; 60(1):150-3. PubMed ID: 1729179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.